These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 8984263)
1. [Everyone and nobody has the responsibility for the future of plasma products]. Sjölin S Lakartidningen; 1996 Nov; 93(46):4137, 4139. PubMed ID: 8984263 [No Abstract] [Full Text] [Related]
2. [Evolution of the practices of labile blood product distribution]. Tardivel R Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509 [No Abstract] [Full Text] [Related]
3. [Developments in blood transfusion]. Krusius T; Porkka K Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306 [No Abstract] [Full Text] [Related]
4. Costs to hospitals of acquiring and processing blood in the US: a survey of hospital-based blood banks and transfusion services. Toner RW; Pizzi L; Leas B; Ballas SK; Quigley A; Goldfarb NI Appl Health Econ Health Policy; 2011; 9(1):29-37. PubMed ID: 21174480 [TBL] [Abstract][Full Text] [Related]
6. Transfusion medicine in Norway: new problems and new opportunities. Flesland O; Seghatchian J Transfus Apher Sci; 2006 Oct; 35(2):93-5. PubMed ID: 17030150 [TBL] [Abstract][Full Text] [Related]
7. Blood banking and transfusion medicine. Past, present and future. Zuck TF J Fla Med Assoc; 1993 Jan; 80(1):20-4. PubMed ID: 8436927 [No Abstract] [Full Text] [Related]
8. [Changes in consumption of blood--the significance of resource related and economic factors]. Solheim BG; Leivestad T; Hanssen LE Tidsskr Nor Laegeforen; 1993 Jan; 113(1):61-5. PubMed ID: 8424254 [TBL] [Abstract][Full Text] [Related]
9. [Threatened future of plasma products. Who is responsible?]. Berntorp E; Nilsson IM; Wollheim FA Lakartidningen; 1996 Oct; 93(40):3443-4. PubMed ID: 8926816 [No Abstract] [Full Text] [Related]
10. Transplantation and transfusion medicine: current and future legal issues. Cooper ES Leg Med; 1990; ():125-45. PubMed ID: 2130193 [No Abstract] [Full Text] [Related]
11. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety]. De Pauw BE; Van den Bos A Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905 [No Abstract] [Full Text] [Related]
13. Innovation in transfusion medicine and blood banking: documenting the record in 50 years of TRANSFUSION. McCullough J Transfusion; 2010 Dec; 50(12):2542-6. PubMed ID: 20667041 [No Abstract] [Full Text] [Related]
14. [Production and consumption of blood and blood products in Norway. Factors of quality assurance in transfusion medicine]. Heier HE Tidsskr Nor Laegeforen; 1993 Jan; 113(1):18-22. PubMed ID: 8424244 [TBL] [Abstract][Full Text] [Related]
15. [The problems of modern transfusion science]. Vorob'ev AI; Dabberkha NM Ter Arkh; 1991; 63(7):4-9. PubMed ID: 1788805 [No Abstract] [Full Text] [Related]
16. The donor of blood and its components. Högman CF Schweiz Med Wochenschr Suppl; 1991; 43():111-4. PubMed ID: 1843033 [No Abstract] [Full Text] [Related]
17. Biotechnology, economics, and the business of blood. Carter TH Biotechnology; 1991; 19():3-30. PubMed ID: 1786473 [No Abstract] [Full Text] [Related]
18. Human blood use market could triple by 1988. MPS; 1980 Feb; 11(2):24. PubMed ID: 10245225 [No Abstract] [Full Text] [Related]
19. [Data processing and blood transfusion activities: fact and future in 2013]. Py JY; Daurat G Transfus Clin Biol; 2013 May; 20(2):243-8. PubMed ID: 23622839 [TBL] [Abstract][Full Text] [Related]
20. Don't let blood products attract budget vampires. Sumwalt D Hosp Mater Manage; 1997 Nov; 22(11):9, 12-3. PubMed ID: 10175301 [No Abstract] [Full Text] [Related] [Next] [New Search]